Comment on “Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-Volume Center Retrospective Cohort Analysis” - Arnar B. Ingason, MD, PhD; Mitchell C. Norotsky, MD, FACS (Annals of Surgery Open)